Study MK0767 and metformin in type 2 diabetic patients (0767-020)
Phase of Trial: Phase III
Latest Information Update: 15 Jul 2014
At a glance
- Drugs Metformin; MK 0767
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 18 Feb 2014 According to the ClinicalTrials.gov record, status changed to discontinued.
- 23 Oct 2007 New trial record.